상세 보기
The 3M roles of the gut microbiome in pharmacotherapy for diabetes: mediator, modifier, and marker
- Seo, J.I.;
- Koh, A.;
- Lim, S.;
- Yoo, H.H.
WEB OF SCIENCE
0SCOPUS
0초록
The rising global prevalence of type 2 diabetes mellitus (T2DM) presents major challenges to healthcare systems; thus, more effective treatment strategies are urgently needed. In this context, the growing recognition of the gut microbiome’s role in T2DM pharmacotherapy has shifted attention toward integrating microbiome-derived mechanisms to optimize drug response. This review proposes a structured ‘3M’ framework that classifies the gut microbiome’s roles in T2DM pharmacotherapy into three translational categories: mediator of drug action, modifier of therapeutic response, and marker for predicting efficacy or intolerance, based on recent clinical and mechanistic insights. Together, these insights support a translational framework that may guide the integration of microbiome-informed strategies into future T2DM pharmacotherapy. © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.; AbstractThe rising global prevalence of type 2 diabetes mellitus (T2DM) presents major challenges to healthcare systems; thus, more effective treatment strategies are urgently needed. In this context, the growing recognition of the gut microbiome’s role in T2DM pharmacotherapy has shifted attention toward integrating microbiome-derived mechanisms to optimize drug response. This review proposes a structured ‘3M’ framework that classifies the gut microbiome’s roles in T2DM pharmacotherapy into three translational categories: mediator of drug action, modifier of therapeutic response, and marker for predicting efficacy or intolerance, based on recent clinical and mechanistic insights. Together, these insights support a translational framework that may guide the integration of microbiome-informed strategies into future T2DM pharmacotherapy. © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
키워드
- 제목
- The 3M roles of the gut microbiome in pharmacotherapy for diabetes: mediator, modifier, and marker
- 저자
- Seo, J.I.; Koh, A.; Lim, S.; Yoo, H.H.
- 발행일
- 2026-07
- 유형
- Article
- 권
- 37
- 호
- 7
- 페이지
- 624 ~ 638